By Lilly Syme on 27-07-2011
Yaupon Therapeutics, Inc., a privately held specialty pharmaceutical company, announced today the submission of a New Drug Application to the U.S. Food and Drug Administration for its propriety gel formulation of mechlorethamine hydrochloride . Yaupon is seeking U.S. marketing approval of its mechlorethamine gel for the treatment of early stage mycosis fungoides, a type of Cutaneous T-Cell Lymphoma . Yaupon’s formulation is a water-soluble, greaseless topical gel.
Read more…
By Lilly Syme on 26-07-2011
Healthcare for all may be a good thing, but spending on staying sound will grow almost 6% each year through 2020 according to experts. Researchers estimate that doctor visits, clinical services and prescription drugs will be some of the largest growth areas, because of the comparably young age of the newly insured population.
The increase is partly due to a percentage of the 30 million people gaining health insurance through President Barack Obama’s healthcare overhaul joining government programs. Read more…
By Brayden Daley on 25-07-2011
A retirement account allows for the tax-free accumulation of savings inside of an investment account. Inheriting retirement accounts from a loved one allows you to carry on your relative’s legacy. You may also use this money for any purpose, including funding your own retirement plan. Certain retirement plans allow you to retitle the investment account if you’re the spouse of the deceased.
Read more…
By Lilly Syme on 25-07-2011
Dyax Corp. and Kadmon Corporation, LLC announced today that Dyax has granted Kadmon a non-exclusive license to Dyax’s proprietary “gold-standard” antibody phage display libraries for the discovery and development of therapeutic antibodies. Dyax’s human antibody phage libraries combine gene fragments from human donors with strategically designed synthetic DNA, and are used to identify high-affinity human antibodies that bind to numerous therapeutic targets, including cell surface proteins such as tumor cell markers, viral antigens, enzymes and glycoproteins.
Samuel D.
Read more…
By Lilly Syme on 24-07-2011
Watson Pharmaceuticals, Inc. today reported net revenue of $1.1 billion for the second quarter ended June 30, 2011, an increase of 24 percent when compared to $875.3 million in the second quarter 2010. On a non-GAAP basis, net income for the second quarter 2011 increased 24 percent to $127.9 million or $1.01 per share, compared to $102.8 million or $0.83 per share in the second quarter 2010. GAAP diluted earnings per share for the second quarter 2011 were $0.42, compared to $0.57 in the prior year period. Watson’s results for the second quarter include the results of Specifar Pharmaceuticals since its acquisition on May 25, 2011. Read more…
By Brayden Daley on 23-07-2011
Tagged Under : Salary
Figuring take-home pay on a yearly salary requires determining the correct percentages for a given income level, then deducting these percentages from the yearly income amount. Some deductions are mandatory like federal, state, Social Security and Medicare taxes. Tax rates change depending on the income level a person receives in a year.
Difficulty: Moderately Easy
-
Read more…
By Lilly Syme on 23-07-2011
“In Guatemala, USAID received basically the same level of funding, about $14 million, over the past two years, and just over $16 million for FY 2011. Cuts are likely ahead, given Washington’s budget crisis,” the publication reports, adding that nutrition effortshave also receivedabout $25 million annually over the last two yearsfrom President Barack Obama’s global food security initiative.
The article describes U.S.-funded programs aimed at reducing chronic malnutrition, such as a “training process for ‘mother leaders’ in the community. A liaison between health care workers and indigenous mothers, they teach women how to cook high-protein plants within their reach” .
Read more…
